Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound

Carcinogenesis

Volumn 26, Issue 4, 2005, Pages 821-826

  Labrecque, Lyne ^a   Lamy, Sylvie ^a   Chapus, Amélie ^a   Mihoubi, Samira ^a   Durocher, Yves ^b   Cass, Brian ^b   Bojanowski, Michel W ^c   Gingras, Denis ^a   Béliveau, Richard ^a,d  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ELLAGIC ACID; PHENOL DERIVATIVE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL MIGRATION; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; ANIMAL; CATTLE; CELL CULTURE; CELL MOTION; DIET; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHOSPHORYLATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; CATTLE; CELL MOVEMENT; CELLS, CULTURED; DIET; ELLAGIC ACID; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 17844384827     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgi024     Document Type: Article

References (24)

1. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1, 27-31.
2. Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V. and Ferrara, N. (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem., 273, 30336-30343.
3. Underiner, T.L., Ruggeri, B. and Gingrich, D.E. (2004) Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. Curr. Med. Chem., 11, 731-745.
4. Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E. and Hanahan, D. (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest., 111, 1287-1295.
5. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med., 6, 389-395.
6. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A. and Betsholtz, C. (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development, 126, 3047-3055.
7. Laird, A.D., Vajkoczy, P., Shawver, L.K., Thurnher, A., Liang, C., Mohammadi, M., Schlessinger, J., Ullrich, A., Hubbard, S.R., Blake, R.A., Fong, T.A., Strawn, L.M., Sun, L., Tang, C., Hawtin, R., Tang, F., Shenoy, N., Hirth, K.P., McMahon, G. and Cherrington, J.M. (2000) SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res., 60, 4152-4160.
8. Daniel, E.M., Kropnick, A.S., Heur, Y.H., Blinzler, J.A., Nims, R.W. and Stoner, G.D. (1990) Extraction, stability, and quantitation of ellagic acid in various fruit and nuts. J. Food Compos. Anal., 2, 338-349.
9. 1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett., 136, 215-221.
10. Lin, S.S., Hung, C.F., Ho, C.C., Liu, Y.H., Ho, H.C. and Chung, J.G. (2000) Effects of ellagic acid by oral administration on N-acetylation and metabolism of 2-aminofluorene in rat brain tissues. Neurochem. Res., 25, 1503-1508.
11. Perchellet, E.M., Sperfslage, B.J., Qabaja, G., Jones, G.B. and Perchellet, J.P. (2001) Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cells more effectively than ellagic acid and genistein in vitro. Anticancer Drugs, 12, 401-417.
12. Kawanishi, K., Ueda, H. and Moriyasu, M. (2003) Aldose reductase inhibitors from the nature. Curr. Med. Chem., 10, 1353-1374.
13. Lamy, S., Gingras, D. and Beliveau, R. (2002) Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res., 62, 381-385.
14. Beliveau, R. and Gingras, D. (2004) Green tea: prevention and treatment of cancer by nutraceuticals. Lancet, 364, 1021-1022.
15. Durocher, Y., Perret, S. and Kamen, A. (2002) High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res., 30, E9.
16. Pham, P.L., Perret, S., Doan, H.C., Cass, B., St-Laurent, G., Kamen, A. and Durocher, Y. (2003) Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency. Biotechnol. Bioeng., 84, 332-342.
17. Guo, D., Jia, Q., Song, H.Y., Warren, R.S. and Donner, D.B. (1995) Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem., 270, 6729-6733.
18. Labrecque, L., Royal, I., Surprenant, D.S., Patterson, C., Gingras, D. and Beliveau, R. (2003) Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol. Biol. Cell, 14, 334-347.
19. Lee, O.H., Kim, Y.M., Lee, Y.M., Moon, E.J., Lee, D.J., Kim, J.H., Kim, K.W. and Kwon, Y.G. (1999) Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun., 264, 743-750.
20. Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Muller, M., Druker, B.J. and Lydon, N.B. (1996) Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res., 56, 100-104.
21. Rousseau, S., Houle, F. and Huot, J. (2000) Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. Trends Cardiovasc. Med., 10, 321-327.
22. Gerhardt, H. and Betsholtz, C. (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res., 314, 15-23.
23. Mertens-Talcott, S.U., Talcott, S.T. and Percival, S.S. (2003) Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J. Nutr., 133, 2669-2674.
24. Lei, F., Xing, D.M., Xiang, L., Zhao, Y.N., Wang, W., Zhang, L.J. and Du, L.J. (2003) Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 796, 189-194.